Emilie Jouanjus

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Topics

Intimate Partner Violence

General Practice

Cross Sectional

Top Venues

British journal of clinical pharmacology

Clinical drug investigation

Fundamental & clinical pharmacology

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Aurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, Morgane Rousselet, Marie Gerardin, Emilie Jouanjus, Frédéric Libert, null null, Marylène Guerlais, Caroline Victorri-Vigneau
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. European journal of public health (2023)
Marion Robert, Emilie Jouanjus, Charles Khouri, Nathalie Fouilhé Sam-Laï, Bruno Revol
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance database. Addiction (Abingdon, England) (2022)
Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef, Maryse Lapeyre Mestre, null null
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. British journal of clinical pharmacology 88 (8) (2022)
Bruno Revol, Maryse Lapeyre Mestre, Nathalie Fouilhé Sam-Laï, Emilie Jouanjus
Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database. British journal of clinical pharmacology 88 (11) (2022)
Fabrice Herin, Jerome Othenin, Emilie Jouanjus, Vanessa Rousseau, Michel Niezborala, Maryse Lapeyre Mestre
Evolution of medication consumption in a working environment in France: Results of the four waves of the "Drugs and Work" study (1986-2016). Pharmacoepidemiology and drug safety 30 (5) (2021)
Emilie Jouanjus, Carla Sans-Pola, Beatrice Mainoli, Farideh A Javid, Isabella Ekheden, null null
Establishing and Evaluating a Study Questionnaire on Knowledge and Attitudes of Healthcare Professionals Towards Recreational and Medical Cannabis Across Europe. Clinical drug investigation 41 (8) (2021)
Emilie Jouanjus, Valérie Gibaja, Florence Fabre, Maryse Lapeyre Mestre, null null
Medical prescription forms of opioid cough suppressants falsified by the patients before and after they switched from OTC to prescription-only in France. British journal of clinical pharmacology (2021)
Emilie Bouquet, Stéphanie Pain, Céline Eiden, Emilie Jouanjus, Nathalie Richard, Bernard Fauconneau, Marie-Christine Pérault-Pochat, null null
Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017). British journal of clinical pharmacology 87 (10) (2021)
Damien Driot, Emilie Jouanjus, Stéphane Oustric, Julie Dupouy, Maryse Lapeyre Mestre
Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France. British journal of clinical pharmacology 85 (6) (2019)
Emilie Jouanjus, Alice Falcou, Sylvie Deheul, Anne Roussin, Maryse Lapeyre Mestre
Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study. Pharmacoepidemiology and drug safety 27 (11) (2018)
Margaux Lafaurie, Liselotte Pochard, Clémence Lotiron, Laurent Molinier, Maryse Lapeyre Mestre, Emilie Jouanjus
Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clinical drug investigation 38 (10) (2018)
Gaétan Gentile, Maeva Jego, Michel Spadari, Karolina Griffiths, Emilie Jouanjus, Joëlle Micallef
Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network? Fundamental & clinical pharmacology 32 (6) (2018)
Emilie Jouanjus, Grégory Guernec, Maryse Lapeyre Mestre, null null
Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion. Fundamental & clinical pharmacology 32 (3) (2018)
Emilie Jouanjus, Michel Mallaret, Joëlle Micallef, Camille Ponté, Anne Roussin, Maryse Lapeyre-Mestre
Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter". Drug safety 40 (2) (2017)